홈
탐색
nav.journalClub
트렌드
더보기
synapse
⌘+K
언어
한국어
한국어
Challenges in assessing statin-associated adverse events | Synapse
June 12, 2026
Challenges in assessing statin-associated adverse events
MB
Marte F. van der Bijl
Erasmus MC
RM
Ruben J M Mijnster
PK
P Hugo M van der Kuy
See all
Key Points
The aim is to identify the challenges in evaluating the adverse events associated with statin therapy.
Identified challenges through literature review and clinical data analysis.
Analyzed patient records for reported adverse events related to statin use.
Explored risk factors contributing to the assessment difficulties.
Reported a high variability in the incidence of statin-associated adverse events.
Identified key risk factors including patient demographics and pre-existing conditions.
Found inconsistencies in reporting practices among healthcare providers.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Bijl et al. (Mon,) studied this question.
synapsesocial.com/papers/6a2bd23b6550ea4541ffea92
https://doi.org/https://doi.org/10.1016/s0140-6736(26)00850-0